Faheem Hasnain - Dec 7, 2022 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
President & CEO, Director
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Stock symbol
GOSS
Transactions as of
Dec 7, 2022
Transactions value $
$0
Form type
4
Date filed
12/9/2022, 04:13 PM
Previous filing
Jul 15, 2022
Next filing
Jan 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +545K $0.00 545K Dec 7, 2022 Common Stock 545K $2.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the total number of shares subject to the option will vest on December 7, 2023 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.